P-Glycoprotein Expression in Breast Cancer
Author Information
Author(s): J. Schneider, M. Bakl, Th. Efferth, M. Kaufmann, J. Mattern, M. Volm
Primary Institution: German Cancer Research Centre, Institute of Experimental Pathology
Hypothesis
Does the expression of P-glycoprotein in breast cancer relate to chemotherapy resistance?
Conclusion
P-glycoprotein is present in human breast cancer at detectable levels only after treatment with multidrug resistance-related chemotherapy, suggesting a link to clinical resistance.
Supporting Evidence
- Three out of seven tumors from patients treated with multidrug resistance-related substances showed clear reactivity.
- Two out of twelve untreated tumors showed isolated positive cells.
- Marked expression of P-glycoprotein was only found in tumors treated with chemotherapy over a longer period.
Takeaway
This study found that a protein called P-glycoprotein is more common in breast cancer cells after patients have received certain types of chemotherapy, which might make the cancer harder to treat.
Methodology
Immunohistochemistry was used to detect P-glycoprotein in tumor samples from patients with and without chemotherapy.
Limitations
The small sample size limits the generalizability of the findings.
Participant Demographics
Patients included both untreated individuals and those treated with various chemotherapy regimens.
Want to read the original?
Access the complete publication on the publisher's website